Alex Nackenoff

Stock Analyst at Truist Financial

(n/a)

# 5,075

Out of 5,082 analysts

2

Total ratings

n/a

Success rate

n/a

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - Specialty & Generic Biotechnology

Stocks Rated by Alex Nackenoff

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ALKS Alkermes	Initiated Coverage: Buy	$55	$44.32	+24.10%	1	Oct 16, 2026
	PTCT PTC Therapeutics	Initiated Coverage: Hold	$62	$62.09	-0.14%	1	Oct 16, 2026

Alkermes

Oct 16, 2026

Initiated Coverage: Buy

Price Target: $55

Current: $44.32

Upside: +24.10%

PTC Therapeutics

Oct 16, 2026

Initiated Coverage: Hold

Price Target: $62

Current: $62.09

Upside: -0.14%